"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A. Deshmukh said.

Deaths from cervical cancer are plummeting among young women in the US, and scientists think we have a single vaccine to thank for the numerous lives saved. In the last decade alone, national health data suggests there has been a 62 percent drop in cervical cancer deaths in women under the age of 25.

A study from MUSC Hollings Cancer Center shows a 62% drop in cervical cancer deaths among women under 25, attributed to HPV vaccination. Despite this success, HPV vaccination rates remain below target,

Although thought of as a disease of middle age, cervical cancer sometimes kills young women as well – but vaccination has made that much rarer.

This study found a steep decline in cervical cancer mortality among US women younger than 25 years between 2016 and 2021.

Cervical cancer deaths among women under 25 have significantly decreased, with researchers at the MUSC Hollings Cancer Center attributing this decline to the widespread use of the HPV vaccine. According to a recent study published in JAMA, cervical cancer mortality in this age group has dropped by 62% over the last decade.

Researchers found a reduction in cervical cancer mortality in women under the age of 25, which is likely due to the introduction of the HPV vaccine.

Research shows a dramatic 62% decrease in cervical cancer mortality in U.S. women under 25, attributed to HPV vaccination and enhanced screening efforts.